← Leaderboards
Evan D Morris
Yale University
$16,421,063
Attributed
$19,803,279
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,803,279 · 15
By mechanism
R01$17,666,604 · 6
R21$2,130,328 · 5
M01$6,347 · 4
Top collaborators
- Suchitra Krishnan-Sarin6 shared
- Joseph N Contessa3 shared
- Kelly P Cosgrove3 shared
- Sule Tinaz1 shared
Most similar at Yale University
Same institution · by research overlap
- David Fiellin$24,843,505
- John H Krystal$70,915,889
- Frederick Lewis Altice$47,021,698
- Suchitra Krishnan-Sarin$33,936,702
- Sandra Ann Springer$27,149,168
Research focus
Positron-Emission TomographyImageResponsePharmaceutical PreparationsInnovationTracerCohortIn VivoBrainScanningBehaviorBaseDopamineResolutionAffectDependenceBrain ImagingDesignCorpus Striatum StructureReceptorReportingResearch PersonnelRacloprideKinetics
Grant awards (39)
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder$711,673
R01 · FY2025 · AA · contact PI
Validation of Occupancy Images from PET Data. A Novel Endpoint for Drug Discovery$581,207
R01 · FY2025 · EB · contact PI
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder$711,752
R01 · FY2024 · AA · contact PI
Validation of Occupancy Images from PET Data. A Novel Endpoint for Drug Discovery$599,250
R01 · FY2024 · EB · contact PI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?$1,033,116
R01 · FY2023 · DA · contact PI
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder$711,808
R01 · FY2023 · AA · contact PI
Validation of Occupancy Images from PET Data. A Novel Endpoint for Drug Discovery$597,847
R01 · FY2023 · EB · contact PI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?$1,126,986
R01 · FY2022 · DA · contact PI
Validation of Occupancy Images from PET Data. A Novel Endpoint for Drug Discovery$647,324
R01 · FY2022 · EB · contact PI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?$1,033,654
R01 · FY2020 · DA · contact PI
Imaging sex differences in smoking-induced dopamine release via novel PET methods$716,421
R01 · FY2020 · DA · contact PI
Imaging Biomarkers of Exercise-Induced Brain Changes in Parkinson's Disease$460,625
R21 · FY2020 · NS · contact PI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?$1,134,658
R01 · FY2019 · DA · contact PI
Imaging sex differences in smoking-induced dopamine release via novel PET methods$724,974
R01 · FY2019 · DA · contact PI
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers$200,000
R01 · FY2019 · AA · contact PI
Does Dopamine Mediate Effects of Stress on Inhibitory Control and Smoking Lapse?$953,150
R01 · FY2018 · DA · contact PI
Imaging sex differences in smoking-induced dopamine release via novel PET methods$733,075
R01 · FY2017 · DA · contact PI
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers$629,961
R01 · FY2017 · AA · contact PI
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer$255,891
R01 · FY2017 · CA · contact PI
Imaging sex differences in smoking-induced dopamine release via novel PET methods$731,997
R01 · FY2016 · DA · contact PI
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers$640,197
R01 · FY2016 · AA · contact PI
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer$257,699
R01 · FY2016 · CA · contact PI
PET-derived 'Dopamine Movies' of Early-Stage Addiction to Cigarette Smoking: A Pilot Study$172,914
R21 · FY2016 · DA · contact PI
Imaging sex differences in smoking-induced dopamine release via novel PET methods$749,137
R01 · FY2015 · DA · contact PI
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers$627,862
R01 · FY2015 · AA · contact PI
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer$254,873
R01 · FY2015 · CA · contact PI
PET-derived 'Dopamine Movies' of Early-Stage Addiction to Cigarette Smoking: A Pilot Study$209,121
R21 · FY2015 · DA · contact PI
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers$636,828
R01 · FY2014 · AA · contact PI
Endotoxin-induced inflammation affects striatal dopamine: A raclopride PET study$249,750
R21 · FY2014 · AG · contact PI
PET imaging of Naltrexone Occupancy of Kappa Receptors in Heavy Drinkers$665,264
R01 · FY2013 · AA · contact PI
Endotoxin-induced inflammation affects striatal dopamine: A raclopride PET study$208,125
R21 · FY2013 · AG · contact PI
Dynamic Dopamine Images: A New View of the Neurochemistry of Smoking$194,014
R21 · FY2013 · DA · contact PI
Dynamic Dopamine Images: A New View of the Neurochemistry of Smoking$243,309
R21 · FY2012 · DA · contact PI
MEASUREMENT OF TEMPORAL CHANGES IN NEUROTRANSMITTER LEVELS VIA PET$29
M01 · FY2008 · RR · contact PI
Temporal Response of Dopamine to Alcohol Imaged via PET$174,689
R21 · FY2007 · AA · contact PI
MEASUREMENT OF TEMPORAL CHANGES IN NEUROTRANSMITTER LEVELS VIA PET$341
M01 · FY2007 · RR · contact PI
Temporal Response of Dopamine to Alcohol Imaged via PET$217,781
R21 · FY2006 · AA · contact PI
MEASUREMENT OF TEMPORAL CHANGES IN NEUROTRANSMITTER LEVELS VIA PET$2,222
M01 · FY2006 · RR · contact PI
MEASUREMENT OF TEMPORAL CHANGES IN NEUROTRANSMITTER LEVELS VIA PET$3,755
M01 · FY2005 · RR